[Form 3] TAKEDA PHARMACEUTICAL CO LTD Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Takeda Pharmaceutical director Emiko Higashi filed an initial ownership report showing equity and award holdings in the company. The filing lists 7,600 American Depositary Shares and 17,800 Ordinary Shares held directly, plus restricted stock units and tax-related awards tied to future vesting.
Footnotes explain that 12,800 restricted stock units each convert into one Ordinary Share, then into American Depositary Shares, vesting on June 1, 2026, 2027, 2028 and upon conclusion of board service. Separate Tax Obligation Awards are each economically equivalent to one Ordinary Share and will be settled in cash at vest primarily to cover tax obligations.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Higashi Emiko
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Tax Obligation Award | -- | -- | -- |
| holding | American Depositary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Tax Obligation Award — 1,152 shares (Direct);
American Depositary Shares — 7,600 shares (Direct);
Ordinary Shares — 17,800 shares (Direct)
Footnotes (1)
- Includes 12,800 restricted stock units (RSUs). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 shares), June 1, 2027 (3,400 shares), June 1, 2028 (3,200 shares) and upon conclusion of the director's board service (3,100 shares). Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Vests upon conclusion of the director's service on the board.
